2 March 2026

Accelerate Research with High-Purity Biosimilar Antibodies

antibodies.com offers over 1.450 biosimilar antibodies. These high-purity, recombinant tools provide a cost-effective, reliable solution for your drug discovery and pre-clinical research.


Obtaining original therapeutic-grade antibodies for drug discovery is often expensive and impractical. To address this challenge, Antibodies.com is offering a comprehensive range of biosimilar antibodies.

What Are Biosimilar Antibodies?

Biosimilars are recombinant monoclonal antibodies that share an identical amino acid sequence with an approved therapeutic antibody. Produced in mammalian cell lines, they are engineered to mimic the specificity, structure, function, and efficacy of the reference product. While natural biological variations (like glycosylation) prevent them from being perfect replicas, these biosimilars are optimised for Research Use Only (RUO). They offer a cost-effective solution for assay development and disease mechanism studies without the high cost of pharmaceutical-grade equivalents.

Uncompromised Quality and Purity

Quality is critical for sensitive research. Our biosimilar antibodies are >95% pure, low endotoxin, and preservative-free. Antibodies.com ensures consistency through rigorous quality control.

  • Purity Assessment: Confirmed via SDS-PAGE and SEC-HPLC to visualise aggregates and ensure monodispersity
  • Bioactivity Testing: Binding affinity established using flow cytometry and ELISA
  • Functional Assays: Validated via internalisation, ADCC, and in vivo inhibition assays

Additionally, formulations utilise histidine and sucrose to maximise protein stability and minimise aggregation.

Applications in Research

Biosimilars serve as excellent benchmarking tools and cost-effective alternatives for:

  • Mechanistic Studies: Investigating biological effects of therapeutics
  • Benchmarking: Comparing new drug candidates during pre-clinical identification
  • Diagnostic Assays: Optimising drug concentrations and dynamic ranges
  • Biophysical Analysis: Characterising binding via Surface Plasmon Resonance (SPR)

Popular Biosimilar Targets

We offer biosimilars for a wide range of popular therapeutic targets from antibodies.com. Below is a selection of frequently requested research targets:

Reference ProductTargetReactivity
AdalimumabAnti-TNF alphaHuman, Mouse, Monkey
RituximabAnti-CD20Human, Cynomolgus
TrastuzumabAnti-HER2Human, Mouse
PembrolizumabAnti-PD1Human, Cynomolgus
NivolumabAnti-PD1Human, Cynomolgus
BevacizumabAnti-VEGFHuman
CetuximabAnti-EGFRHuman, Mouse, Cynomolgus

Accelerate Research with High-Purity Biosimilar Antibodies

Related articles

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support
Contact